APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Injectable Ketamine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Injectable Ketamine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174003160326 December 2025199 pages

Choose your research edition.

Industry ResearchInjectable Ketamine Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Injectable Ketamine Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Injectable Ketamine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Injectable Ketamine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Injectable Ketamine Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Injectable Ketamine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Injectable Ketamine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Injectable Ketamine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Injectable Ketamine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Injectable Ketamine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Injectable Ketamine include Anhui Wanhe Pharmaceutical, Pfizer, Hengrui, Troikaa Parenterals, Taj Pharmaceuticals, Supriya Lifesciences, Sun Pharmaceuticals, Seqens and Samarth Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Injectable Ketamine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Injectable Ketamine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Injectable Ketamine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Injectable Ketamine market size, projected growth trends, production technologies, key applications, and end-use industries.

Injectable Ketamine Segment by Company

Anhui Wanhe Pharmaceutical

Pfizer

Hengrui

Troikaa Parenterals

Taj Pharmaceuticals

Supriya Lifesciences

Sun Pharmaceuticals

Seqens

Samarth Pharma

Neon Laboratories

Ketalar

Hameln Pharma ltd

Greenco Biologicals

BNM Organics

Injectable Ketamine Segment by Type

Standard Ketamine

Low-Dose Ketamine

High-Dose Ketamine

Injectable Ketamine Segment by Application

Mental Health Treatment

Pain Management

Anesthetic Use

Injectable Ketamine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Injectable Ketamine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Injectable Ketamine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Injectable Ketamine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Injectable Ketamine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Injectable Ketamine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Injectable Ketamine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Injectable Ketamine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Injectable Ketamine Industry Trends Table 2. Injectable Ketamine Industry Drivers Table 3. Injectable Ketamine Industry Opportunities and Challenges Table 4. Injectable Ketamine Industry Restraints Table 5. Global Injectable Ketamine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Injectable Ketamine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Injectable Ketamine Sales by Manufacturers (Kg) & (2021-2026) Table 8. Global Injectable Ketamine Sales Market Share by Manufacturers Table 9. Global Injectable Ketamine Average Sales Price (US$/g) of Manufacturers (2021-2026) Table 10. Global Injectable Ketamine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Injectable Ketamine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Injectable Ketamine Manufacturers, Product Type & Application Table 13. Global Injectable Ketamine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Injectable Ketamine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Standard Ketamine Table 17. Major Manufacturers of Low-Dose Ketamine Table 18. Major Manufacturers of High-Dose Ketamine Table 19. Global Injectable Ketamine Sales by Type 2021 VS 2025 VS 2032 (Kg) Table 20. Global Injectable Ketamine Sales by Type (2021-2026) & (Kg) Table 21. Global Injectable Ketamine Sales by Type (2027-2032) & (Kg) Table 22. Global Injectable Ketamine Sales Market Share by Type (2021-2026) Table 23. Global Injectable Ketamine Sales Market Share by Type (2027-2032) Table 24. Global Injectable Ketamine Revenue by Type 2021 VS 2025 VS 2032 (Kg) Table 25. Global Injectable Ketamine Revenue by Type (2021-2026) & (Kg) Table 26. Global Injectable Ketamine Revenue by Type (2027-2032) & (Kg) Table 27. Global Injectable Ketamine Revenue Market Share by Type (2021-2026) Table 28. Global Injectable Ketamine Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Mental Health Treatment Table 30. Major Manufacturers of Pain Management Table 31. Major Manufacturers of Anesthetic Use Table 32. Global Injectable Ketamine Sales by Application 2021 VS 2025 VS 2032 (Kg) Table 33. Global Injectable Ketamine Sales by Application (2021-2026) & (Kg) Table 34. Global Injectable Ketamine Sales by Application (2027-2032) & (Kg) Table 35. Global Injectable Ketamine Sales Market Share by Application (2021-2026) Table 36. Global Injectable Ketamine Sales Market Share by Application (2027-2032) Table 37. Global Injectable Ketamine Revenue by Application 2021 VS 2025 VS 2032 (Kg) Table 38. Global Injectable Ketamine Revenue by Application (2021-2026) & (Kg) Table 39. Global Injectable Ketamine Revenue by Application (2027-2032) & (Kg) Table 40. Global Injectable Ketamine Revenue Market Share by Application (2021-2026) Table 41. Global Injectable Ketamine Revenue Market Share by Application (2027-2032) Table 42. Global Injectable Ketamine Sales by Region: 2021 VS 2025 VS 2032 (Kg) Table 43. Global Injectable Ketamine Sales by Region (2021-2026) & (Kg) Table 44. Global Injectable Ketamine Sales Market Share by Region (2021-2026) Table 45. Global Injectable Ketamine Sales Forecasted by Region (2027-2032) & (Kg) Table 46. Global Injectable Ketamine Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Injectable Ketamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 48. North America Injectable Ketamine Sales by Country (2021-2026) & (Kg) Table 49. North America Injectable Ketamine Sales by Country (2027-2032) & (Kg) Table 50. Europe Injectable Ketamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 51. Europe Injectable Ketamine Sales by Country (2021-2026) & (Kg) Table 52. Europe Injectable Ketamine Sales by Country (2027-2032) & (Kg) Table 53. Asia Pacific Injectable Ketamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 54. Asia Pacific Injectable Ketamine Sales by Country (2021-2026) & (Kg) Table 55. Asia Pacific Injectable Ketamine Sales by Country (2027-2032) & (Kg) Table 56. South America, Middle East and Africa Injectable Ketamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 57. South America, Middle East and Africa Injectable Ketamine Sales by Country (2021-2026) & (Kg) Table 58. South America, Middle East and Africa Injectable Ketamine Sales by Country (2027-2032) & (Kg) Table 59. Global Injectable Ketamine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Injectable Ketamine Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Injectable Ketamine Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Injectable Ketamine Revenue Market Share by Region (2021-2026) Table 63. Global Injectable Ketamine Revenue Market Share by Region (2027-2032) Table 64. Anhui Wanhe Pharmaceutical Company Information Table 65. Anhui Wanhe Pharmaceutical Business Overview Table 66. Anhui Wanhe Pharmaceutical Injectable Ketamine Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Anhui Wanhe Pharmaceutical Injectable Ketamine Product Portfolio Table 68. Anhui Wanhe Pharmaceutical Recent Development Table 69. Pfizer Company Information Table 70. Pfizer Business Overview Table 71. Pfizer Injectable Ketamine Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Pfizer Injectable Ketamine Product Portfolio Table 73. Pfizer Recent Development Table 74. Hengrui Company Information Table 75. Hengrui Business Overview Table 76. Hengrui Injectable Ketamine Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Hengrui Injectable Ketamine Product Portfolio Table 78. Hengrui Recent Development Table 79. Troikaa Parenterals Company Information Table 80. Troikaa Parenterals Business Overview Table 81. Troikaa Parenterals Injectable Ketamine Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Troikaa Parenterals Injectable Ketamine Product Portfolio Table 83. Troikaa Parenterals Recent Development Table 84. Taj Pharmaceuticals Company Information Table 85. Taj Pharmaceuticals Business Overview Table 86. Taj Pharmaceuticals Injectable Ketamine Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Taj Pharmaceuticals Injectable Ketamine Product Portfolio Table 88. Taj Pharmaceuticals Recent Development Table 89. Supriya Lifesciences Company Information Table 90. Supriya Lifesciences Business Overview Table 91. Supriya Lifesciences Injectable Ketamine Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Supriya Lifesciences Injectable Ketamine Product Portfolio Table 93. Supriya Lifesciences Recent Development Table 94. Sun Pharmaceuticals Company Information Table 95. Sun Pharmaceuticals Business Overview Table 96. Sun Pharmaceuticals Injectable Ketamine Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Sun Pharmaceuticals Injectable Ketamine Product Portfolio Table 98. Sun Pharmaceuticals Recent Development Table 99. Seqens Company Information Table 100. Seqens Business Overview Table 101. Seqens Injectable Ketamine Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Seqens Injectable Ketamine Product Portfolio Table 103. Seqens Recent Development Table 104. Samarth Pharma Company Information Table 105. Samarth Pharma Business Overview Table 106. Samarth Pharma Injectable Ketamine Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Samarth Pharma Injectable Ketamine Product Portfolio Table 108. Samarth Pharma Recent Development Table 109. Neon Laboratories Company Information Table 110. Neon Laboratories Business Overview Table 111. Neon Laboratories Injectable Ketamine Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Neon Laboratories Injectable Ketamine Product Portfolio Table 113. Neon Laboratories Recent Development Table 114. Ketalar Company Information Table 115. Ketalar Business Overview Table 116. Ketalar Injectable Ketamine Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Ketalar Injectable Ketamine Product Portfolio Table 118. Ketalar Recent Development Table 119. Hameln Pharma ltd Company Information Table 120. Hameln Pharma ltd Business Overview Table 121. Hameln Pharma ltd Injectable Ketamine Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Hameln Pharma ltd Injectable Ketamine Product Portfolio Table 123. Hameln Pharma ltd Recent Development Table 124. Greenco Biologicals Company Information Table 125. Greenco Biologicals Business Overview Table 126. Greenco Biologicals Injectable Ketamine Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Greenco Biologicals Injectable Ketamine Product Portfolio Table 128. Greenco Biologicals Recent Development Table 129. BNM Organics Company Information Table 130. BNM Organics Business Overview Table 131. BNM Organics Injectable Ketamine Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. BNM Organics Injectable Ketamine Product Portfolio Table 133. BNM Organics Recent Development Table 134. Key Raw Materials Table 135. Raw Materials Key Suppliers Table 136. Injectable Ketamine Distributors List Table 137. Injectable Ketamine Customers List Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources Table 141. Primary Sources List of Figures Figure 1. Injectable Ketamine Product Image Figure 2. Global Injectable Ketamine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Injectable Ketamine Market Size (2021-2032) & (US$ Million) Figure 4. Global Injectable Ketamine Sales (2021-2032) & (Kg) Figure 5. Global Injectable Ketamine Average Price (US$/g) & (2021-2032) Figure 6. Global Top 5 and 10 Injectable Ketamine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Standard Ketamine Image Figure 9. Low-Dose Ketamine Image Figure 10. High-Dose Ketamine Image Figure 11. Global Injectable Ketamine Sales by Type (2021 VS 2025 VS 2032) & (Kg) Figure 12. Global Injectable Ketamine Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Injectable Ketamine Sales Market Share by Type (2021-2032) Figure 14. Global Injectable Ketamine Revenue by Type (2021 VS 2025 VS 2032) & (Kg) Figure 15. Global Injectable Ketamine Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Injectable Ketamine Revenue Market Share by Type (2021-2032) Figure 17. Mental Health Treatment Image Figure 18. Pain Management Image Figure 19. Anesthetic Use Image Figure 20. Global Injectable Ketamine Sales by Application (2021 VS 2025 VS 2032) & (Kg) Figure 21. Global Injectable Ketamine Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Injectable Ketamine Sales Market Share by Application (2021-2032) Figure 23. Global Injectable Ketamine Revenue by Application (2021 VS 2025 VS 2032) & (Kg) Figure 24. Global Injectable Ketamine Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Injectable Ketamine Revenue Market Share by Application (2021-2032) Figure 26. North America Injectable Ketamine Sales and Growth Rate (2021-2032) & (Kg) Figure 27. North America Injectable Ketamine Sales Market Share by Country (2021-2032) Figure 28. U.S. Injectable Ketamine Sales and Growth Rate (2021-2032) & (Kg) Figure 29. Canada Injectable Ketamine Sales and Growth Rate (2021-2032) & (Kg) Figure 30. Mexico Injectable Ketamine Sales and Growth Rate (2021-2032) & (Kg) Figure 31. Europe Injectable Ketamine Sales and Growth Rate (2021-2032) & (Kg) Figure 32. Europe Injectable Ketamine Sales Market Share by Country (2021-2032) Figure 33. Germany Injectable Ketamine Sales and Growth Rate (2021-2032) & (Kg) Figure 34. France Injectable Ketamine Sales and Growth Rate (2021-2032) & (Kg) Figure 35. U.K. Injectable Ketamine Sales and Growth Rate (2021-2032) & (Kg) Figure 36. Italy Injectable Ketamine Sales and Growth Rate (2021-2032) & (Kg) Figure 37. Netherlands Injectable Ketamine Sales and Growth Rate (2021-2032) & (Kg) Figure 38. Asia Pacific Injectable Ketamine Sales and Growth Rate (2021-2032) & (Kg) Figure 39. Asia Pacific Injectable Ketamine Sales Market Share by Country (2021-2032) Figure 40. China Injectable Ketamine Sales and Growth Rate (2021-2032) & (Kg) Figure 41. Japan Injectable Ketamine Sales and Growth Rate (2021-2032) & (Kg) Figure 42. South Korea Injectable Ketamine Sales and Growth Rate (2021-2032) & (Kg) Figure 43. Southeast Asia Injectable Ketamine Sales and Growth Rate (2021-2032) & (Kg) Figure 44. India Injectable Ketamine Sales and Growth Rate (2021-2032) & (Kg) Figure 45. Australia Injectable Ketamine Sales and Growth Rate (2021-2032) & (Kg) Figure 46. South America, Middle East and Africa Injectable Ketamine Sales and Growth Rate (2021-2032) & (Kg) Figure 47. South America, Middle East and Africa Injectable Ketamine Sales Market Share by Country (2021-2032) Figure 48. Brazil Injectable Ketamine Sales and Growth Rate (2021-2032) & (Kg) Figure 49. South Africa Injectable Ketamine Sales and Growth Rate (2021-2032) & (Kg) Figure 50. Saudi Arabia Injectable Ketamine Sales and Growth Rate (2021-2032) & (Kg) Figure 51. Turkey Injectable Ketamine Sales and Growth Rate (2021-2032) & (Kg) Figure 52. Argentina Injectable Ketamine Sales and Growth Rate (2021-2032) & (Kg) Figure 53. UAE Injectable Ketamine Sales and Growth Rate (2021-2032) & (Kg) Figure 54. Egypt Injectable Ketamine Sales and Growth Rate (2021-2032) & (Kg) Figure 55. Chile Injectable Ketamine Sales and Growth Rate (2021-2032) & (Kg) Figure 56. Global Injectable Ketamine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Injectable Ketamine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Injectable Ketamine Revenue (2021-2032) & (US$ Million) Figure 59. North America Injectable Ketamine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Injectable Ketamine Revenue (2021-2032) & (US$ Million) Figure 61. Europe Injectable Ketamine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Injectable Ketamine Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Injectable Ketamine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Injectable Ketamine Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Injectable Ketamine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Injectable Ketamine Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Injectable Ketamine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Standard Ketamine
  • Low-Dose Ketamine
  • High-Dose Ketamine
Applications
  • Mental Health Treatment
  • Pain Management
  • Anesthetic Use
Companies covered
  • Anhui Wanhe Pharmaceutical
  • Pfizer
  • Hengrui
  • Troikaa Parenterals
  • Taj Pharmaceuticals
  • Supriya Lifesciences
  • Sun Pharmaceuticals
  • Seqens
  • Samarth Pharma
  • Neon Laboratories
  • Ketalar
  • Hameln Pharma ltd
  • Greenco Biologicals
  • BNM Organics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Injectable Ketamine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Injectable Ketamine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Injectable Ketamine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Injectable Ketamine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Injectable Ketamine Market Dynamics
  1. 2.1 Injectable Ketamine Industry Trends
  2. 2.2 Injectable Ketamine Industry Drivers
  3. 2.3 Injectable Ketamine Industry Opportunities and Challenges
  4. 2.4 Injectable Ketamine Industry Restraints
3 Injectable Ketamine Market by Manufacturers
  1. 3.1 Global Injectable Ketamine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Injectable Ketamine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Injectable Ketamine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Injectable Ketamine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Injectable Ketamine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Injectable Ketamine Manufacturers, Product Type & Application
  7. 3.7 Global Injectable Ketamine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Injectable Ketamine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Injectable Ketamine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Injectable Ketamine Tier 1, Tier 2, and Tier 3
4 Injectable Ketamine Market by Type
  1. 4.1 Injectable Ketamine Type Introduction
  2. 4.1.1 Standard Ketamine
  3. 4.1.2 Low-Dose Ketamine
  4. 4.1.3 High-Dose Ketamine
  5. 4.2 Global Injectable Ketamine Sales by Type
  6. 4.2.1 Global Injectable Ketamine Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Injectable Ketamine Sales by Type (2021-2032)
  8. 4.2.3 Global Injectable Ketamine Sales Market Share by Type (2021-2032)
  9. 4.3 Global Injectable Ketamine Revenue by Type
  10. 4.3.1 Global Injectable Ketamine Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Injectable Ketamine Revenue by Type (2021-2032)
  12. 4.3.3 Global Injectable Ketamine Revenue Market Share by Type (2021-2032)
5 Injectable Ketamine Market by Application
  1. 5.1 Injectable Ketamine Application Introduction
  2. 5.1.1 Mental Health Treatment
  3. 5.1.2 Pain Management
  4. 5.1.3 Anesthetic Use
  5. 5.2 Global Injectable Ketamine Sales by Application
  6. 5.2.1 Global Injectable Ketamine Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Injectable Ketamine Sales by Application (2021-2032)
  8. 5.2.3 Global Injectable Ketamine Sales Market Share by Application (2021-2032)
  9. 5.3 Global Injectable Ketamine Revenue by Application
  10. 5.3.1 Global Injectable Ketamine Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Injectable Ketamine Revenue by Application (2021-2032)
  12. 5.3.3 Global Injectable Ketamine Revenue Market Share by Application (2021-2032)
6 Global Injectable Ketamine Sales by Region
  1. 6.1 Global Injectable Ketamine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Injectable Ketamine Sales by Region (2021-2032)
  3. 6.2.1 Global Injectable Ketamine Sales by Region (2021-2026)
  4. 6.2.2 Global Injectable Ketamine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Injectable Ketamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Injectable Ketamine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Injectable Ketamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Injectable Ketamine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Injectable Ketamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Injectable Ketamine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Injectable Ketamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Injectable Ketamine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Injectable Ketamine Revenue by Region
  1. 7.1 Global Injectable Ketamine Revenue by Region
  2. 7.1.1 Global Injectable Ketamine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Injectable Ketamine Revenue by Region (2021-2026)
  4. 7.1.3 Global Injectable Ketamine Revenue by Region (2027-2032)
  5. 7.1.4 Global Injectable Ketamine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Injectable Ketamine Revenue (2021-2032)
  8. 7.2.2 North America Injectable Ketamine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Injectable Ketamine Revenue (2021-2032)
  11. 7.3.2 Europe Injectable Ketamine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Injectable Ketamine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Injectable Ketamine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Injectable Ketamine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Injectable Ketamine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Anhui Wanhe Pharmaceutical
  2. 8.1.1 Anhui Wanhe Pharmaceutical Company Information
  3. 8.1.2 Anhui Wanhe Pharmaceutical Business Overview
  4. 8.1.3 Anhui Wanhe Pharmaceutical Injectable Ketamine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Anhui Wanhe Pharmaceutical Injectable Ketamine Product Portfolio
  6. 8.1.5 Anhui Wanhe Pharmaceutical Recent Developments
  7. 8.2 Pfizer
  8. 8.2.1 Pfizer Company Information
  9. 8.2.2 Pfizer Business Overview
  10. 8.2.3 Pfizer Injectable Ketamine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer Injectable Ketamine Product Portfolio
  12. 8.2.5 Pfizer Recent Developments
  13. 8.3 Hengrui
  14. 8.3.1 Hengrui Company Information
  15. 8.3.2 Hengrui Business Overview
  16. 8.3.3 Hengrui Injectable Ketamine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Hengrui Injectable Ketamine Product Portfolio
  18. 8.3.5 Hengrui Recent Developments
  19. 8.4 Troikaa Parenterals
  20. 8.4.1 Troikaa Parenterals Company Information
  21. 8.4.2 Troikaa Parenterals Business Overview
  22. 8.4.3 Troikaa Parenterals Injectable Ketamine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Troikaa Parenterals Injectable Ketamine Product Portfolio
  24. 8.4.5 Troikaa Parenterals Recent Developments
  25. 8.5 Taj Pharmaceuticals
  26. 8.5.1 Taj Pharmaceuticals Company Information
  27. 8.5.2 Taj Pharmaceuticals Business Overview
  28. 8.5.3 Taj Pharmaceuticals Injectable Ketamine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Taj Pharmaceuticals Injectable Ketamine Product Portfolio
  30. 8.5.5 Taj Pharmaceuticals Recent Developments
  31. 8.6 Supriya Lifesciences
  32. 8.6.1 Supriya Lifesciences Company Information
  33. 8.6.2 Supriya Lifesciences Business Overview
  34. 8.6.3 Supriya Lifesciences Injectable Ketamine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Supriya Lifesciences Injectable Ketamine Product Portfolio
  36. 8.6.5 Supriya Lifesciences Recent Developments
  37. 8.7 Sun Pharmaceuticals
  38. 8.7.1 Sun Pharmaceuticals Company Information
  39. 8.7.2 Sun Pharmaceuticals Business Overview
  40. 8.7.3 Sun Pharmaceuticals Injectable Ketamine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sun Pharmaceuticals Injectable Ketamine Product Portfolio
  42. 8.7.5 Sun Pharmaceuticals Recent Developments
  43. 8.8 Seqens
  44. 8.8.1 Seqens Company Information
  45. 8.8.2 Seqens Business Overview
  46. 8.8.3 Seqens Injectable Ketamine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Seqens Injectable Ketamine Product Portfolio
  48. 8.8.5 Seqens Recent Developments
  49. 8.9 Samarth Pharma
  50. 8.9.1 Samarth Pharma Company Information
  51. 8.9.2 Samarth Pharma Business Overview
  52. 8.9.3 Samarth Pharma Injectable Ketamine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Samarth Pharma Injectable Ketamine Product Portfolio
  54. 8.9.5 Samarth Pharma Recent Developments
  55. 8.10 Neon Laboratories
  56. 8.10.1 Neon Laboratories Company Information
  57. 8.10.2 Neon Laboratories Business Overview
  58. 8.10.3 Neon Laboratories Injectable Ketamine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Neon Laboratories Injectable Ketamine Product Portfolio
  60. 8.10.5 Neon Laboratories Recent Developments
  61. 8.11 Ketalar
  62. 8.11.1 Ketalar Company Information
  63. 8.11.2 Ketalar Business Overview
  64. 8.11.3 Ketalar Injectable Ketamine Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Ketalar Injectable Ketamine Product Portfolio
  66. 8.11.5 Ketalar Recent Developments
  67. 8.12 Hameln Pharma ltd
  68. 8.12.1 Hameln Pharma ltd Company Information
  69. 8.12.2 Hameln Pharma ltd Business Overview
  70. 8.12.3 Hameln Pharma ltd Injectable Ketamine Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Hameln Pharma ltd Injectable Ketamine Product Portfolio
  72. 8.12.5 Hameln Pharma ltd Recent Developments
  73. 8.13 Greenco Biologicals
  74. 8.13.1 Greenco Biologicals Company Information
  75. 8.13.2 Greenco Biologicals Business Overview
  76. 8.13.3 Greenco Biologicals Injectable Ketamine Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Greenco Biologicals Injectable Ketamine Product Portfolio
  78. 8.13.5 Greenco Biologicals Recent Developments
  79. 8.14 BNM Organics
  80. 8.14.1 BNM Organics Company Information
  81. 8.14.2 BNM Organics Business Overview
  82. 8.14.3 BNM Organics Injectable Ketamine Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 BNM Organics Injectable Ketamine Product Portfolio
  84. 8.14.5 BNM Organics Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Injectable Ketamine Value Chain Analysis
  2. 9.1.1 Injectable Ketamine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Injectable Ketamine Production Mode & Process
  6. 9.2 Injectable Ketamine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Injectable Ketamine Distributors
  9. 9.2.3 Injectable Ketamine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst